• LY2603618: Chk1 Inhibitor Workflow Guide

  2026-08-26

  LY2603618 is a selective Chk1 inhibitor for mapping DNA damage, G2/M checkpoint failure, and chemotherapy response in cancer models. This guide combines practical dosing, assay design, iPSC-inspired prescreening logic, and troubleshooting for more reproducible translational studies.

• FPS-ZM1: A Selective RAGE Inhibitor

  2026-08-26

  FPS-ZM1 is a blood-brain barrier-permeable RAGE inhibitor for mechanistic studies of amyloid beta (Aβ) signaling and neuroinflammation. Product information describes selective blockade of RAGE binding by Aβ40 and Aβ42, while recent berberine research independently identifies RAGE/POMC signaling as a CNS mechanism in metabolic disease.

• BMS-777607 Workflows for MET and Platelet Research

  2026-08-25

  Build reproducible BMS-777607 assays for c-Met phosphorylation, tumor-cell invasion, and exploratory megakaryocyte maturation studies. This guide separates evidence-backed benchmarks from practical starting conditions so researchers can evaluate MET signaling pathway inhibition without overextending the platelet literature.

• AICAR Phosphate (Acadesine): AMPK Research Guide

  2026-08-25

  AICAR phosphate, also called Acadesine, is a cell-permeable AMPK research activator that requires intracellular phosphorylation for activity. Product data report dose-dependent apoptosis in B-cell chronic lymphocytic leukemia cells, while model-specific validation remains essential.

• Dual-Action Kinase Inhibitors and p38α Dephosphorylation

  2026-08-24

  The reference study shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can expose the activation-loop phosphothreonine and accelerate its removal by the phosphatase WIP1. This structural mechanism provides a framework for designing inhibitors that combine direct kinase blockade with phosphatase-facilitated pathway shutoff.

• Dibutyryl-cAMP: Designing Better Signaling Assays

  2026-08-24

  Discover how Dibutyryl-cAMP, sodium salt can function as a controlled cAMP perturbation for mechanistic assay design, including PKA readouts and brain-slice studies. This guide connects DBcAMP sodium salt with translational model selection while clarifying what the compound can—and cannot—demonstrate.

• Red Blood Cell Membrane Bending Rigidity Explained

  2026-08-23

  Himbert and colleagues isolated the mechanical contribution of the red blood cell cytoplasmic membrane from that of the spectrin network using X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations. Their estimate of approximately 4–6 kBT indicates that the membrane itself is unusually soft, clarifying why previously reported whole-cell bending moduli varied so widely.

• Optimized hiPSC Differentiation for Functional Platelets

  2026-08-22

  This 2026 study develops an optimized differentiation scheme that increases megakaryocyte and platelet production from human induced pluripotent stem cells while shortening culture time and reducing cost. Its combination of embryoid-body optimization, human platelet lysate, and small-molecule modulation provides a practical framework for scalable platelet manufacturing, although broader validation is still needed.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-08-22

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled cardiovascular and renal experiments involving the renin-angiotensin system. It is appropriate for hypertension research and related aldosterone or blood pressure assays, but should not be treated as a validated reagent for unrelated pathways, clinical use, or quantitative potency claims without additional evidence.

• Aneugen Molecular Mechanism Assay: Key Findings

  2026-08-21

  Bernacki and colleagues developed a tiered flow-cytometric strategy that distinguishes tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition after detecting aneugenic activity. Its combination of fluorescent Taxol, phospho-histone H3, Ki-67, hierarchical clustering, and an artificial neural network offers a practical framework for moving beyond a binary genotoxicity result toward molecular interpretation.

• FGF4-FGFR1 Signaling in Diabetic Kidney Disease

  2026-08-20

  The reference study identifies podocyte-derived FGF4 as an endogenous protective factor in diabetic kidney disease and links its loss to worsening glomerular injury. Genetic deletion and recombinant-protein rescue experiments indicate that FGF4 acts through an FGFR1–AMPK–FOXO1 pathway to reduce oxidative stress, apoptosis, and podocyte loss in male mice.

• Carbapenemase Transmission in Guangdong CREC

  2026-08-20

  This 2025 BMC Microbiology study integrates carbapenemase-gene localization, conjugation testing, mobile-element analysis, and strain typing to examine carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. Its findings show that blaNDM−1 was frequently plasmid-associated and readily transferable, emphasizing the value of combining resistance surveillance with transmission-focused laboratory analysis.

• PP 2 (AG 1879): Reliable Src Assay Design

  2026-08-19

  A scenario-based guide to using PP 2 (AG 1879), SKU A8216, in cell proliferation, viability, cytotoxicity, and signal-transduction workflows. It connects biochemical selectivity, solvent handling, concentration interpretation, and vendor-selection criteria to practical laboratory decisions.

• Pexidartinib (PLX3397) for TAM Assays

  2026-08-19

  Use Pexidartinib (PLX3397) as a controlled CSF1R perturbation tool to separate macrophage survival effects from direct tumor-cell responses. This workflow pairs CSF1R-mediated signaling inhibition with SPP1-focused phenotyping, enabling clearer interpretation of tumor microenvironment macrophage modulation in translational cancer research.

• 0.4% Trypan Blue Solution: Practical Cell Counting

  2026-08-18

  0.4% Trypan Blue Solution provides a simple endpoint method for cell viability measurement, cell counting, and live/dead cell discrimination in research cell suspensions. It is intended for scientific research workflows such as culture monitoring and cytotoxicity assays, but it should not be used as a diagnostic, medical, or standalone apoptosis and necrosis detection test.

8457 records 1/564 page Next 12345 下5页 Last page